Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-16

Clinical Trial Update: Machado-Joseph Disease in Israel

View source ↗

Summary

A clinical trial update concerning Machado-Joseph disease (Spinocerebellar Ataxia Type 3) in Israel; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Meir Medical Center | Conditions: Spinocerebellar Ataxia 3 | Status: UNKNOWN